Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial

BACKGROUND: China's three inactivated enterovirus A71 (EV-A71) vaccines are the first and currently world's only EV-A71 vaccines approved by a national regulatory authority and used to prevent EV-A71 associated diseases. The three vaccines vary by vaccine strain, manufacturing cell substra...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Gao, Fan, Wang, Yamin, Li, Jing, Zhang, Yuxi, Lv, Huakun, Wang, Shenyu, Yang, Haitao, Liu, Xiaoqiang, Li, Keli, Wang, Huaqing, Yin, Zundong, Liang, Zhenglun, An, Zhijie, Mao, Qunying, Feng, Zijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579145/
https://www.ncbi.nlm.nih.gov/pubmed/34881371
http://dx.doi.org/10.1016/j.lanwpc.2021.100284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579145/
https://www.ncbi.nlm.nih.gov/pubmed/34881371
http://dx.doi.org/10.1016/j.lanwpc.2021.100284

Ejemplares similares